Literature DB >> 28818471

Basic principles of test-negative design in evaluating influenza vaccine effectiveness.

Wakaba Fukushima1, Yoshio Hirota2.   

Abstract

Based on the unique characteristics of influenza, the concept of "monitoring" influenza vaccine effectiveness (VE) across the seasons using the same observational study design has been developed. In recent years, there has been a growing number of influenza VE reports using the test-negative design, which can minimize both misclassification of diseases and confounding by health care-seeking behavior. Although the test-negative designs offer considerable advantages, there are some concerns that widespread use of the test-negative design without knowledge of the basic principles of epidemiology could produce invalid findings. In this article, we briefly review the basic concepts of the test-negative design with respect to classic study design such as cohort studies or case-control studies. We also mention selection bias, which may be of concern in some countries where rapid diagnostic testing is frequently used in routine clinical practices, as in Japan.
Copyright © 2017. Published by Elsevier Ltd.

Keywords:  Control selection; Effectiveness; Influenza vaccine; Rapid diagnostic testing; Selection bias; Test-negative design

Mesh:

Substances:

Year:  2017        PMID: 28818471     DOI: 10.1016/j.vaccine.2017.07.003

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  26 in total

1.  Bias of influenza vaccine effectiveness estimates from test-negative studies conducted during an influenza pandemic.

Authors:  Kylie E C Ainslie; Michael Haber; Walter A Orenstein
Journal:  Vaccine       Date:  2019-03-02       Impact factor: 3.641

2.  Challenges in estimating influenza vaccine effectiveness.

Authors:  Kylie E C Ainslie; Michael Haber; Walt A Orenstein
Journal:  Expert Rev Vaccines       Date:  2019-05-31       Impact factor: 5.217

3.  Immune correlates analysis using vaccinees from test negative designs.

Authors:  Dean A Follmann; Lori Dodd
Journal:  Biostatistics       Date:  2022-04-13       Impact factor: 5.279

4.  The Impact of Influenza Vaccination on Antibiotic Use in the United States, 2010-2017.

Authors:  Eili Y Klein; Emily Schueller; Katie K Tseng; Daniel J Morgan; Ramanan Laxminarayan; Arindam Nandi
Journal:  Open Forum Infect Dis       Date:  2020-06-06       Impact factor: 3.835

5.  Incorporating Real-time Influenza Detection Into the Test-negative Design for Estimating Influenza Vaccine Effectiveness: The Real-time Test-negative Design (rtTND).

Authors:  Leora R Feldstein; Wesley H Self; Jill M Ferdinands; Adrienne G Randolph; Michael Aboodi; Adrienne H Baughman; Samuel M Brown; Matthew C Exline; D Clark Files; Kevin Gibbs; Adit A Ginde; Michelle N Gong; Carlos G Grijalva; Natasha Halasa; Akram Khan; Christopher J Lindsell; Margaret Newhams; Ithan D Peltan; Matthew E Prekker; Todd W Rice; Nathan I Shapiro; Jay Steingrub; H Keipp Talbot; M Elizabeth Halloran; Manish Patel
Journal:  Clin Infect Dis       Date:  2021-05-04       Impact factor: 9.079

6.  Trends in Influenza Vaccine Uptake and Severe Influenza-Related Outcomes at Kaiser Permanente Southern California, 2007-2017.

Authors:  In-Lu Amy Liu; Hilary C Tanenbaum; Lei Qian; Lina S Sy; Wansu Chen; Steven J Jacobsen
Journal:  Perm J       Date:  2021-05

7.  An evaluation of a test-negative design for EV-71 vaccine from a randomized controlled trial.

Authors:  Li Zhang; Mingwei Wei; Pengfei Jin; Jingxin Li; Fengcai Zhu
Journal:  Hum Vaccin Immunother       Date:  2021-02-02       Impact factor: 3.452

8.  Severe Acute Respiratory Infection (SARI) sentinel surveillance in the country of Georgia, 2015-2017.

Authors:  Giorgi Chakhunashvili; Abram L Wagner; Laura E Power; Cara B Janusz; Ann Machablishvili; Irakli Karseladze; Olgha Tarkhan-Mouravi; Khatuna Zakhashvili; Paata Imnadze; Gregory C Gray; Benjamin Anderson; Matthew L Boulton
Journal:  PLoS One       Date:  2018-07-30       Impact factor: 3.240

9.  Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019.

Authors:  Esther Kissling; Angela Rose; Hanne-Dorthe Emborg; Alin Gherasim; Richard Pebody; Francisco Pozo; Ramona Trebbien; Clara Mazagatos; Heather Whitaker; Marta Valenciano
Journal:  Euro Surveill       Date:  2019-02

10.  Effectiveness of EV-A71 vaccination in prevention of paediatric hand, foot, and mouth disease associated with EV-A71 virus infection requiring hospitalisation in Henan, China, 2017-18: a test-negative case-control study.

Authors:  Yu Li; Yonghong Zhou; Yibing Cheng; Peng Wu; Chongchen Zhou; Peng Cui; Chunlan Song; Lu Liang; Fang Wang; Qi Qiu; Chun Guo; Mengyao Zeng; Lu Long; Benjamin J Cowling; Hongjie Yu
Journal:  Lancet Child Adolesc Health       Date:  2019-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.